Tag - NGNE

Developments

Neurogene announces treatment intended to reverse HLH associated with high-dose AAV

Neurogene (NASDAQ:NGNE) has announced an oral presentation at the American Society of Gene and Cell Therapy (ASGCT) annual meeting this week describing a monitoring and treatment algorithm intended to reverse the rare...

May 16, 2025

Developments

Neurogene and Neoleukin in merger accord

Close-held Neurogene and Neoleukin Therapeutics (NASDAQ:NLTX) entered into a definitive merger agreement to combine the companies in an all-stock transaction. The combined company will focus on advancing Neurogene’s...

July 18, 2023

Tag - NGNE

Neurogene announces treatment intended to reverse HLH associated with high-dose AAV

Neurogene and Neoleukin in merger accord

Subscribe